News | October 07, 2022
Glenmark launches Lobeglitazone in India for Uncontrolled Type 2 Diabetes in adults
Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg).
Glenmark is the first company in India to launch Thiazolidinedione Lobeglitazone (0.5 mg).
Dr. Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.
Ours is a story of India’s resilient public health system and of everyone working together as team India to battle the pandemic
The companies will leverage their respective proprietary technology platforms
Charsire Biotechnology Corp. has successfully developed a revolutionary new drug (BAC) for Alzheimer's disease
Aster Pharmacy will be operated by GD Assist Limited in Bangladesh.
This association between the two esteemed organizations allows Medvarsity to significantly – and positively – impact healthcare education
The Allurion Program is suited for people who are unable to achieve their weight-loss goals by dieting alone or for those who do not want to, or cannot, undergo invasive surgery or endoscopy
Under the terms of the agreement, Lonza can now provide its customers with seamless access to Touchlight’s enzymatic DNA technology
Hello Patients provides healthcare billing and patients’ management solution
Subscribe To Our Newsletter & Stay Updated
